author-photo

Bernard Zinman

University of Toronto
Lunenfeld-Tanenbaum Research Institute
Mount Sinai Hospital, Toronto

560

Papers

60801

Citations

Citation Trend

Filter By

Papers (560) Sort By

Journal Conference Others

Author response for "Effects of Empagliflozin on Insulin Initiation or Intensification in Patients with Type 2 Diabetes and Cardiovascular Disease: Findings from the EMPA‐REG OUTCOME ® Trial"

2021 Diabetes, Obesity and Metabolism
Show All
- Source
- Cite
- Save
Citations (0)
Subtypes of gestational diabetes and future risk of pre-diabetes or diabetes

2021 EClinicalMedicine
Show All
- Source
- Cite
- Save
Citations (0)
Empagliflozin Reduces Myocardial Extracellular Volume in Patients With Type 2 Diabetes and Coronary Artery Disease.

2021 Jacc-cardiovascular Imaging
Show All
- Source
- Cite
- Save
Citations (10)
790-P: Empagliflozin Reduced the Total Burden of Events Leading to or Prolonging Hospitalization in EMPA-REG OUTCOME

2021 Diabetes
Show All
- Source
- Cite
- Save
Citations (0)
Author response for "The Ongoing Evolution of Basal Insulin Therapy over 100 Years and its Promise for the Future"

2021 Diabetes, Obesity and Metabolism
- Ravi Retnakaran
- Bernard Zinman
Show All
- Source
- Cite
- Save
Citations (0)
Author response for "Empagliflozin and uric acid metabolism in diabetes: a post‐hoc analysis of the EMPA‐REG OUTCOME trial"

2021 Diabetes, Obesity and Metabolism
Show All
- Source
- Cite
- Save
Citations (0)
Author response for "The Effects of Canagliflozin on Heart Failure and Cardiovascular Death by Baseline Participant Characteristics: Analysis of the CREDENCE Trial"

2021 Diabetes, Obesity and Metabolism
Show All
- Source
- Cite
- Save
Citations (0)
Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes: the CARMELINA randomized controlled trial

2021 Ndt Plus
Show All
- Source
- Cite
- Save
Citations (2)
The ongoing evolution of basal insulin therapy over 100 years and its promise for the future

2021 Diabetes, Obesity and Metabolism
- Ravi Retnakaran
- Bernard Zinman
Show All
- Source
- Cite
- Save
Citations (0)
Author response for "Effect of empagliflozin on cardiorenal outcomes and mortality according to body‐mass index: A subgroup analysis of the EMPA‐REG OUTCOME trial with a focus on Asia"

2021 Diabetes, Obesity and Metabolism
Show All
- Source
- Cite
- Save
Citations (0)